KI, OUH, Research unit of Clinical Immunology (Odense)

Medicine & Life Sciences

1. Alleles 14%
2. Anti-Citrullinated Protein Antibodies 10%
3. Antibodies 52%
4. Antibody Formation 18%
5. Antibody-Producing Cells 26%
6. Antigens 14%
7. Aquaporin 4 15%
8. Autoantibodies 14%
9. B-Lymphocytes 25%
10. Biomarkers 21%
11. Biopsy 10%
12. Blood Donors 100%
13. Blood Group Antigens 25%
14. Blood Platelets 17%
15. Blood Safety 12%
16. Blood Transfusion 24%
17. Celiac Disease 37%
18. Cerebrospinal Fluid 12%
19. Child 25%
20. Chimeric Antigen Receptors 19%
21. Chimerism 17%
22. Chronic Hepatitis C 10%
23. Cohort Studies 43%
24. Confidence Intervals 20%
25. Conjugate Vaccines 22%
26. Coronavirus 30%
27. Coronavirus Infections 13%
28. Cost-Benefit Analysis 11%
29. Cross-Sectional Studies 15%
30. Denmark 89%
31. Encephalitis 10%
32. Enzyme-Linked Immunosorbent Assay 13%
33. Epidemiology 12%
34. Erythema Infectiosum 10%
35. Erythrocytes 15%
36. Exons 10%
37. Familial Mediterranean Fever 10%
38. Fecal Microbiota Transplantation 16%
39. Genes 23%
40. Genotype 10%
41. Haemophilus influenzae type b 35%
42. Health 10%
43. Hemorrhage 11%
44. Hepacivirus 12%
45. Hepatitis B 16%
46. Hepatitis C 13%
47. Hidradenitis Suppurativa 9%
48. HLA Antigens 10%
49. HLA-A Antigens 10%
50. Human Parvovirus B19 11%
51. Immunoglobulin A 22%
52. Immunoglobulin G 42%
53. Immunoglobulin M 20%
54. In Vitro Techniques 11%
55. Incidence 13%
56. Infections 29%
57. Iron 14%
58. Messenger RNA 11%
59. Meta-Analysis 10%
60. microfibrillar protein 19%
61. Migraine Disorders 11%
62. Mortality 10%
63. Mothers 12%
64. Multiple Myeloma 13%
65. Multiple Sclerosis 20%
66. Mutation 17%
67. Neoplasms 10%
68. Neuromyelitis Optica 34%
69. Odds Ratio 12%
70. Optic Neuritis 23%
71. Pandemics 15%
72. Parvovirus 12%
73. Phenotype 13%
74. Platelet Aggregation 13%
75. Polysaccharides 26%
76. Population 33%
77. Pregnancy 14%
78. Pregnant Women 12%
79. Prospective Studies 14%
80. Randomized Controlled Trials 10%
81. Registries 13%
82. Rheumatoid Arthritis 26%
83. RHO(D) antibody 11%
84. SARS Virus 57%
85. Seroepidemiologic Studies 16%
86. Serum 16%
87. Severe Acute Respiratory Syndrome 28%
88. Stem Cells 9%
89. Sweden 9%
90. Systematic Reviews 13%
91. T-Lymphocytes 35%
92. Tetanus Toxoid 11%
93. Therapeutics 17%
94. Tissue Donors 32%
95. Transplants 10%
96. Twin Studies 16%
97. Twins 11%
98. Vaccination 29%
99. Vaccines 21%
100. Virus Diseases 13%